{"schema_version":"secwatch.filing_event.v1","accession":"0001618835-23-000017","form_type":"8-K","ticker":"EVFM","cik":"0001618835","company_name":"Evofem Biosciences, Inc.","filed_at":"2023-03-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.850924+00:00","generated_at":"2026-06-17T23:35:52.584214+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Evofem stockholders approve reverse stock split of 1-for-20 to 1-for-125","bullets":["Special Meeting held March 15, 2023; 67.96% of eligible shares represented.","Approval: 132,595,045 for, 23,270,478 against, 1,693,299 abstain.","Board has discretion to set exact ratio as a whole number within 1:20 to 1:125 range.","Reverse split must be effected on or before March 15, 2024.","Company's common stock trades on OTCQB under symbol EVFM."],"urls":{"canonical":"https://secwatch.observer/filing/0001618835-23-000017","json":"https://secwatch.observer/filing/0001618835-23-000017.json","markdown":"https://secwatch.observer/filing/0001618835-23-000017.md","text":"https://secwatch.observer/filing/0001618835-23-000017.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1618835/000161883523000017/0001618835-23-000017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1618835/000161883523000017/evfm-20230315.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T23:35:52.584214+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"12b2b2fddf4522a362bff10cbce17a07faa051e4","claim":"Evofem Biosciences, Inc. shareholders approved Approval of an amendment to the Company's Certificate of Incorporation to effectuate a reverse stock split of the outstanding shares of the Company's common stock by a ratio of not less than 1-for-20 and not more than 1-for-125 at any time on or prior to March 15, 2024, with the exact ratio to be se at the 2023-03-15 meeting.","evidence_excerpt":"Proposal No. 1: The Company’s stockholders approved an amendment to the Company’s Certificate of Incorporation to effectuate a reverse stock split of the outstanding shares of the Company’s common stock by a ratio of not less than 1-for-20 and not more than 1-for-125 at any time on or prior to March 15, 2024, with the exact ratio to be set at a whole number within such range by the Company’s board of directors (the “Board”), at the sole discretion of the Board, as follows: Votes For Votes Against Abstentions Broker Non-Votes 132,595,045 23,270,478 1,693,299 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883523000017/0001618835-23-000017-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"reverse split"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-03-15"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}